Cure of established, intracerebral rat gliomas induced by therapeutic immunizations with tumor cells and purified APC or adjuvant IFN-γ treatment

Journal of Immunotherapy

Volumn 19, Issue 5, 1996, Pages 334-345

  Siesjö, Peter ^a,b   Visse, Edward ^a   Sjögren, Hans Olov ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b Department of Marcus   (Sweden)

Author keywords

Brain neoplasm; Dendritic cell; Immunization; Interferon ; Rat; Sex difference

Indexed keywords

GAMMA INTERFERON; MUTAGENIC AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTING CELL; ARTICLE; CANCER ADJUVANT THERAPY; CANCER GRAFT; CANCER IMMUNIZATION; CANCER IMMUNOTHERAPY; CANCER SURVIVAL; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; GLIOMA; IMMUNOGENICITY; INTRACEREBRAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; ISOGRAFT; MALE; NONHUMAN; OSMOTIC PUMP; PRIORITY JOURNAL; RAT; SEX DIFFERENCE; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; ANTIGEN-PRESENTING CELLS; BRAIN; BRAIN NEOPLASMS; CHEMOTHERAPY, ADJUVANT; FEMALE; GLIOMA; IMMUNOTHERAPY, ADOPTIVE; INTERFERON TYPE II; MALE; RATS; RATS, INBRED F344; SEX FACTORS;

EID: 0029959095     PISSN: 10538550     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. Kornblith PL, William CW, Bardley MK. The future therapy for glioblastoma. Surg Neurol 1993;39:538-43.
2. Bodmer S, Strommer K, Frei K, et al. Immunosuppression and transforming growth factor-β in glioblastoma. Preferential production of transforming growth factor-β2. J Immunol 1989;143: 3222-9.
3. de Micco C, Hassoun J, Meyer G, Toga M. Role of the blood-brain barrier in the establishment of the immune response against polyoma virus-induced cerebral tumors in hamsters. J Neuroimmun 1986;11:301-10.
4. Kojima K, Berger T, Lassmann H, et al. Experimental autoimmune panencephalitis and uveoretinitis transferred to the Lewis rat by T lymphocytes specific for the S100-beta molecule, a calcium binding protein of astroglia. J Exp Med 1994;180:817-29.
5. Sedgwick JD, MacPhee IAM, Puklavec M. Isolation of encephalitogenic CD4+ T cell, clones in the rat: Cloning methodology and interferon-gamma secretion. J Immunol Method 1989;121:185-96.
6. Obwegeser A, Ortler M, Seiwald M, Ulmer H, Kostron H. Therapy of glioblastoma multiforme: a cumulative experience of 10 years. Acta Neurochir 1995;137:29-33.
7. Kida Y, Cravioto H, Hochwald GM, Hochgeschwender U, Ransohoff J. Immunity to transplantable nitrosourea-induced neurogenic tumors II. Immunoprophylaxis of tumors of the brain. J Neuropathol Exp Neurol 1983;42:122-35.
8. McCutcheon IE, Baranco RA, Katz DA, Saris SC. Adoptive immunotherapy of intracerebral metastases in mice. J Neurosurg 1990;72:102-9.
9. Holladay FP, Heitz T, Chen YL, Chiga M, Woo GW. Successful treatment of a malignant rat glioma with cytotoxic T lymphocytes. Neurosargery 1992;31:528-33.
10. Yumitori K, Ito Y, Handa H. Protective effect of immunization with virus-infected glioma cells against intracerebrally implanted glioma in mice. Eur J Cancer Clin Oncol 1982;18:177-81.
11. Lampson LA, Wen P, Roman VA, Morris JH, Sarid JA. Disseminating tumor cells and their interactions with leukocytes visualized in the brain. Cancer Res 1992;52:1018-25.
12. Pedersen PH, Edvardsen K, Garcia C-I, et al. Migratory patterns of lac-z transfected human glioma cells in the rat brain. Int J Cancer 1995;62:767-71.
13. - variants: immunogenic variants obtained by mutagen treatment of tumor cells, Immunol Today 1985;6:307-11.
14. Frost P, Kerbel RS, Bauer E, Tartamello-Biondo R, Cefalu W. Mutagen treatment as a means for selecting immunogenic variants from otherwise poorly immunogenic malignant murine tumors. Cancer Res 1983;43:125-32.
15. Guery JC, Adorini L. Dendritic cells are the most efficient in presenting endogenous naturally processed self-epitopes to class II-restricted tumor cells. J Immunol 1995;154:536-44.
16. Macatonia SE, Taylor PM, Knight SC, Askonas BA. Primary stimulation by dendritic cells induces antiviral proliferative and cytotoxic t cell responses in-vitro. J Exp Med 1989;169:1255-64.
17. Mehta-Damani A, Markowicz S, Engleman EG. Generation of antigen-specific CD8+ CTLs from naive precursors. J Immunol 1994;153:996-1003.
18. Bevan MJ. Antigen presentation to cytotoxic T lymphocytes in vivo. J Exp Med 1995;182:639-41.
19. Rock KL, Rothstein L, Gamble S, Fleischacker C. Characterization of antigen-presenting cells that present exogenous antigens in association with class I MHC molecules. J Immunol 1993;150:438-46.
20. Nair S, Babu JS, Dunham RG, Kanda P, Burke RL, Rouse BT. Induction of primary antiviral cytotoxic and proliferative responses with antigens administered via dendritic cells. J Virol 1993;67: 4062-9.
21. Levin D, Constant S, Pasqualini T, Flavell R, Bottomly K. Role of dendritic cells in the priming of CD4 T lymphocytes to peptide antigen in vivo. J Immunol 1993;151:6742-50.
22. Kanangat S, Nair S, Babu JS, Rouse BT. Expression of cytokine mRNA in murine splenic dendritic cells and better induction of T cell-derived cytokines by dendritic cells than by macrophages during in vitro costimulation assay using specific antigen. J Leukocyte Biol 1995;57:310-6.
23. De Bruijn MLH, Nieland JD, Harding CV, Melief CJM. Processing and presentation of intact hen egg-white lysozyme by dendritic cells. Eur J Immunol 1992;22:2347-52.
24. Inaba K, Inaba M, Naito M, Steinman RM. Dendritic cell progenitors phagocytose particulates including bacillus Calmette-Guerin organisms and sensitize mice to mycobacterial antigens in-vivo. J Exp Med 1993;178:479-88.
25. Cohen PJ, Cohen PA, Rosenberg SA, Katz SI, Mule JJ. Murine epidermal Langerhans cells and splenic dendritic cells present tumor-associated antigens to primed T cells. Eur J Immunol 1994; 24:315-9.
26. Paglia P, Chiodoni C, Rodolfo M, Colombo MP. Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo. J Exp Med 1996;183:317-22.
27. Zitvogel L, Mayordomo JI, Tjandrawan T, et al. Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1 associated cytokines. J Exp Med 1996;183:87-97.
28. Cumberbatch M, Kimber I. Tumour necrosis factor-alpha is required for accumulation of dendritic cells in draining lymph nodes and for optimal contact sensitization. Immunology 1995;84: 31-5.
29. Mackay CR, Marston WL, Dudler L. Naive and memory t cells show distinct pathways of lymphocyte recirculation. J Exp Med 1990;171:801-18.
30. Arnold D, Faath S, Rammensee HG, Schild H. Cross-priming of minor histocompatibility antigen-specific cytotoxic T cells upon immunization with the heat shock protein gp96. J Exp Med 1995; 182:885-9.
31. Srivastava PK, Udono H, Blachere NE, Li Z. Heat shock proteins transfer peptides during antigen processing and CTL priming. Immunogenet 1994;39:93-8.
32. -) cells causes rejection of N32 rat glioma. Cancer Immunol Immunother 1993;7:56-62.
33. Damoiseaux JGMC, Dopp EA, Neefjes JJ, Beelen RHJ, Dijkstra CD. Hetereogeneity of macrophages in the rat evidenced by variability in determinants two new anti-rat macrophage antibodies against a heterodimer of 160 and 95-kD CD11-CD18. J Leukocyte Biol 1989;46:556-64.
34. Dijkstra CD, Dopp EA, Joling P, Kraal G. The heterogeneity of mononuclear phagocytes in lymphoid organs distinct macrophage subpopulations in the rat recognized by monoclonal antibodies ED-1, ED-2 and ED-3. Immunology 1985;54:589-600.
35. Judge TA, Liu M, Christensen PJ, Fak JJ, Turka LA. Cloning the rat homolog of the CD28-CTLA-4-ligand B7-1: Structural and functional analysis. Int Immunol 1995;7:171-8.
36. Gabathuler R, Reid G, Kolaitis G, Driscoll J, Jefferies WA. Comparison of cell lines deficient in antigen presentation reveals a functional role for TAP-1 alone in antigen processing. J Exp Med 1994;180:1415-25.
37. Young HA, Hardy KJ. Role of interferon-gamma in immune cell regulation. J Leukocyte Biol 1995;58:373-81.
38. Sad S, Mosmann TR. Interleukin (IL) 4, in the absence of antigen stimulation, induces an anergy-like state in differentiated CD8+ TC1 cells: Loss of IL-2 synthesis and autonomous proliferation but retention of cytotoxicity and synthesis of other cytokines. J Exp Med 1995;182:1505-15.
39. Openshaw P, Murphy EE, Hosken NA, et al. Heterogeneity of intracellular cytokine synthesis at the single-cell level in polarized T helper 1 and T helper 2 populations. J Exp Med 1995;182:1357-67.
40. Flesch IEA, Hess JH, Huang S, et al. Early interleukin 12 production by macrophages in response to mycobacterial infection depends on Interferon gamma and tumor necrosis factor alpha. J Exp Med 1995;181:1615-21.
41. Ma X, Chow JM, Gri G, et al. The interleukin 12 p40 gene promoter is primed by interferon γ in monocytic cells. J Exp Med 1996;183:147-57.
42. Staib L, Harel W, Mitchell MS. Protection against experimental cerebral metastases of murine melanoma B16 by active immunization. Cancer Res 1993;53:1113-21.
43. Wen PY, Lampson MA, Lampson LA. Effects of gamma interferon on major histocompatibility complex antigen expression and lymphocytic infiltration in the 91 gliosarcoma brain tumor model implications for strategies of immunotherapy. J Neuroimmunol 1992;36:57-68.
44. Mondino A, Jenkins MK. Surface proteins involved in T cell Costimulation. J Leukocyte Biol 1994;55:805-15.
45. Lu L, Hsieh M, Oriss TB, et al. Generation of DC from mouse spleen cell cultures in response to GM-CSF: Immunophenotypic and functional analyses. Immunology 1995;84:127-34.
46. Macatonia SE, Hsieh CS, Murphy KM, O'Garra A. Dendritic cells and macrophages are required for Th1 development of CD4 positive T cells from alpha-beta TCR transgenic mice IL-12 substitution for macrophages to stimulate IFN-gamma production is IFN-gamma-dependent. Int Immunol 1993;5:1119-28.
47. Okamura H, Tsutsui H, Komatsu T, et al. Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature 1995; 378:88-91.
48. Critchfield JM, Racke MK, Zuniga PJC, et al. T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis. Science 1994;263:1139-43.
49. Constant S, Pfeiffer C, Woodard A, Pasqualini T, Bottomly K. Extent of T cell receptor ligation can determine the functional differentiation of naive CD4+ T cells. J Exp Med 1995;182: 1591-6.
50. Hosken NA, Shibuya K, Health AW, Murphy KM, O'G A. The effect of antigen dose on CD4+ T helper cell phenotype development in a T cell receptor-alpha-beta-transgenic model. J Exp Med 1995;182:1579-84.
51. Kearney ER, Pape KA, Loh DY, Jenkins MK. Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo. Immunity 1994;1:327-39.
52. Grossman C. Possible underlying mechanisms of sexual dimorphism in the immune response: fact and hypothesis. J Steroid Biochem 1989;34:241-52.
53. Satoskar A, Alexander J. Sex-determined susceptibility and differential IFN-gamma and TNF-alpha mRNA expression in DBA-2 mice infected with Leishmania mexicana. Immunology 1995;84:1-4.
54. Viselli SM, Stanziale S, Shults K, Kovacs WJ, Olsen NJ. Castration alters peripheral immune function in normal male mice. Immunology 1995;84:337-42.
55. Araneo BA, Dowell T, Diegel M, Daynes RA. Dihydrotestosterone exerts a depressive influence on the production of IL-4, IL-5 and gamma IFN but not IL-2 by activated murine t cells. Blood 1991; 78:688-99.
56. Fox HS, Bond BL, Parslow TG. Estrogen regulates the IFN-gamma promoter. J Immunol 1991;146:4362-7.
57. Zuckerman SH, Bryan P-N, Evans GF, Short L, Glasebrook AL. In vivo modulation of murine serum tumour necrosis factor and interleukin-6 levels during endotoxemia by oestrogen agonists and antagonists. Immunology 1995;86:18-24.
58. Vandervegt FP, Johnson LL, Induction of long-term H-Y-specific tolerance in female mice given male lymphoid cells while transiently depleted of CD4 positive or CD8 positive T cells. J Exp Med 1993;177:1587-92.
59. Wettstein PJ, Korngold R. T cell subsets required for in-vivo and in-vitro responses to single and multiple minor histocompatibility antigens. Transplantation 1992;54:296-307.
60. Johnson LL. Failure of a tumor to prime CTL specific for some of the minor H antigens it expresses but not others. Immunology 1991;72:532-6.